San Francisco, CA, Oct. 29, 2018 (GLOBE NEWSWIRE) -- 3Scan, Inc. (3Scan
[https://www.globenewswire.com/Tracker?data=vjrBl3wa2ho5eeEnG6fG2KcW4Pek10DkXIsVH2KsUbMDqlZ6Fc6cOThozbWng0Do]
), the world’s leading 3D tissue imaging company has been awarded a Phase I
Small Business Innovation Research (SBIR) grant from the National Institute of
Diabetes and Digestive and Kidney Diseases